Bayesian two-stage design for drug screening trials with switching hypothesis tests based on continuous endpoints (Q5079049)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian two-stage design for drug screening trials with switching hypothesis tests based on continuous endpoints |
scientific article; zbMATH DE number 7532130
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bayesian two-stage design for drug screening trials with switching hypothesis tests based on continuous endpoints |
scientific article; zbMATH DE number 7532130 |
Statements
Bayesian two-stage design for drug screening trials with switching hypothesis tests based on continuous endpoints (English)
0 references
25 May 2022
0 references
single-to-double arm design
0 references
continuous endpoints
0 references
Bayesian error rates
0 references
